Contraction of experimental wounds. I. Inhibiting wound contraction by using a topical smooth muscle antagonist.
D000287:Administration, Topical; D000818:Animals; D003094:Collagen / Q000096:biosynthesis; D004048:Diethylamines / Q000494:pharmacology; D004158:Diphenylacetic Acids / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005347:Fibroblasts / Q000187:drug effects; D006097:Granulation Tissue / Q000166:cytology / Q000187:drug effects*; D008297:Male; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects; D009210:Myofibrils / Q000187:drug effects; D011392:Proline / Q000378:metabolism; D014176:Protein Biosynthesis; D011817:Rabbits; D012867:Skin / Q000293:injuries; D012965:Sodium Chloride / Q000494:pharmacology; D013440:Sulfides / Q000494:pharmacology; D014316:Tritium; D014945:Wound Healing / Q000187:drug effects*
D004048:Diethylamines; D004158:Diphenylacetic Acids; D009125:Muscle Relaxants, Central; D013440:Sulfides; D014316:Tritium; D012965:Sodium Chloride; D003094:Collagen; D011392:Proline